177 related articles for article (PubMed ID: 17290100)
1. Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-reactive protein.
Artieda M; Cenarro A; Gañán A; Lukic A; Moreno E; Puzo J; Pocoví M; Civeira F
Cardiology; 2007; 108(4):297-306. PubMed ID: 17290100
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
3. Pre-operative high sensitive C-reactive protein predicts cardiovascular events after coronary artery bypass grafting surgery: a prospective observational study.
Balciunas M; Bagdonaite L; Samalavicius R; Griskevicius L; Vuylsteke A
Ann Card Anaesth; 2009; 12(2):127-32. PubMed ID: 19602737
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
Ridker PM; Hennekens CH; Buring JE; Rifai N
N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
[TBL] [Abstract][Full Text] [Related]
5. Serum chitotriosidase activity is increased in subjects with atherosclerosis disease.
Artieda M; Cenarro A; Gañán A; Jericó I; Gonzalvo C; Casado JM; Vitoria I; Puzo J; Pocoví M; Civeira F
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1645-52. PubMed ID: 12893688
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
Sattar N; Murray HM; McConnachie A; Blauw GJ; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Murphy MB; Packard CJ; Perry IJ; Stott DJ; Sweeney BJ; Twomey C; Westendorp RG; Shepherd J;
Circulation; 2007 Feb; 115(8):981-9. PubMed ID: 17283264
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
[TBL] [Abstract][Full Text] [Related]
9. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
10. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.
Koenig W; Löwel H; Baumert J; Meisinger C
Circulation; 2004 Mar; 109(11):1349-53. PubMed ID: 15023871
[TBL] [Abstract][Full Text] [Related]
12. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study.
van der Meer IM; de Maat MP; Kiliaan AJ; van der Kuip DA; Hofman A; Witteman JC
Arch Intern Med; 2003 Jun; 163(11):1323-8. PubMed ID: 12796068
[TBL] [Abstract][Full Text] [Related]
13. Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation.
Lund J; Qin QP; Ilva T; Pettersson K; Voipio-Pulkki LM; Porela P; Pulkki K
Circulation; 2003 Oct; 108(16):1924-6. PubMed ID: 14530192
[TBL] [Abstract][Full Text] [Related]
14. Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.
Huang SS; Huang PH; Chen YH; Sung SH; Chiang KH; Chen JW; Lin SJ
Coron Artery Dis; 2008 Dec; 19(8):597-602. PubMed ID: 18971786
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein predicts further ischemic events in transient ischemic attack patients.
Purroy F; Montaner J; Molina CA; Delgado P; Arenillas JF; Chacon P; Quintana M; Alvarez-Sabin J
Acta Neurol Scand; 2007 Jan; 115(1):60-6. PubMed ID: 17156267
[TBL] [Abstract][Full Text] [Related]
17. Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease.
Falcone C; Minoretti P; D'Angelo A; Buzzi MP; Coen E; Emanuele E; Aldeghi A; Olivieri V; Geroldi D
Eur J Clin Invest; 2006 Apr; 36(4):211-7. PubMed ID: 16620281
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
Haim M; Benderly M; Tanne D; Matas Z; Boyko V; Fisman EZ; Tenenbaum A; Zimmlichman R; Battler A; Goldbourt U; Behar S
Am Heart J; 2007 Dec; 154(6):1095-101. PubMed ID: 18035081
[TBL] [Abstract][Full Text] [Related]
19. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
Benn M; Nordestgaard BG; Jensen GB; Tybjaerg-Hansen A
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):661-70. PubMed ID: 17170368
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events.
Vainas T; Stassen FR; de Graaf R; Twiss EL; Herngreen SB; Welten RJ; van den Akker LH; van Dieijen-Visser MP; Bruggeman CA; Kitslaar PJ
J Vasc Surg; 2005 Aug; 42(2):243-51. PubMed ID: 16102622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
